2023
Entrant Company
Category
Client's Name
Country / Region
Unlocking the Proteome -The NULISA™ Platform sets a new standard in proteomic analysis with attomolar sensitivity, allowing for unprecedented biomarker detection and quantitation.
By leveraging a proprietary sequential immunocomplex capture and release mechanism and the latest advances in Next Generation Sequencing (NGS), the NULISA technology provides both ultra-high sensitivity and scalable multiplexing.
Credits
Entrant Company
Atrium Health
Category
Strategic Program - Digital Marketing Campaign
Country / Region
United States
Entrant Company
Mnemonic Agency
Category
Video - TV Ad Campaign
Country / Region
United States
Entrant Company
OnePlus
Category
Video - Viral
Country / Region
China
Entrant Company
PACO Collective
Category
Advertising - Magazine Ad (Campaign)
Country / Region
United States